| Literature DB >> 34073056 |
Leonore Novak1, Maria Petrosino1, Daniele Santorelli1, Roberta Chiaraluce1, Valerio Consalvi1, Alessandra Pasquo2, Carlo Travaglini-Allocatelli1.
Abstract
Bromodomains (BRDs) are small protein interaction modules of about 110 amino acids that selectively recognize acetylated lysine in histones and other proteins. These domains have beenpan> idenpan>tified in a variety of multi-domain proteins involved in transcriptional regulation or chromatin remodeling in eukaryotic cells. BRD inhibition is considered an attractive therapeutic approach in epigenpan>etic disorders, particularly in oncology. Here, we presenpan>t a Φ value analysis to investigate the folding pathway of the second domain of BRD2 (BRD2(2)). Using an extensive mutational analysis based on 25 site-directed mutants, we provide structural information on both the intermediate and late transition state of BRD2(2). The data reveal that the C-terminal region represents part of the initial folding nucleus, while the N-terminal region of the domain consolidates its structure only later in the folding process. Furthermore, only a small number of native-like interactions have been identified, suggesting the presence of a non-compact, partially folded state with scarce native-like characteristics. Taken together, these results indicate that, in BRD2(2), a hierarchical mechanism of protein folding can be described with non-native interactions that play a significant role in folding.Entities:
Keywords: bromodomain; folding kinetics; mutagenesis; protein folding; protein stability; Φ value analysis
Year: 2021 PMID: 34073056 DOI: 10.3390/ijms22115953
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923